| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA38048
Max Phase: Preclinical
Molecular Formula: C6H11IO4
Molecular Weight: 274.05
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC1O[C@@H](O)C(I)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C6H11IO4/c1-2-4(8)5(9)3(7)6(10)11-2/h2-6,8-10H,1H3/t2?,3?,4-,5-,6-/m1/s1
Standard InChI Key: MUPURZLMTOXIFL-YHMDAOSXSA-N
Associated Targets(Human)
SW613 29 Activities
Associated Targets(non-human)
L1210 27553 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 274.05 | Molecular Weight (Monoisotopic): 273.9702 | AlogP: -0.75 | #Rotatable Bonds: 0 |
| Polar Surface Area: 69.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.36 | CX Basic pKa: | CX LogP: -0.11 | CX LogD: -0.11 |
| Aromatic Rings: 0 | Heavy Atoms: 11 | QED Weighted: 0.40 | Np Likeness Score: 1.98 |
References
| 1. Sufrin JR, Bernacki RJ, Morin MJ, Korytnyk W.. (1980) Halogenated L-fucose and D-galactose analogues: synthesis and metabolic effects., 23 (2): [PMID:7359528] [10.1021/jm00176a008] |
Source
Source(1):